Usage: VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine receptor (AChR) antibodies.
vyvgart hytrulo - efgartigimod alfa and hyaluronidase
(Efgartigimod Alfa And Hyaluronidase (Human Recombinant))